235 related articles for article (PubMed ID: 36232614)
1. Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers.
Thiruchenthooran V; Świtalska M; Bonilla L; Espina M; García ML; Wietrzyk J; Sánchez-López E; Gliszczyńska A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232614
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
Kamel AE; Fadel M; Louis D
Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
[TBL] [Abstract][Full Text] [Related]
3. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
4. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
Truong TH; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Muangnoi C; Nalinratana N; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Carbohydr Polym; 2022 Jul; 288():119401. PubMed ID: 35450653
[TBL] [Abstract][Full Text] [Related]
7. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines.
Chand P; Kumar H; Badduri N; Gupta NV; Bettada VG; Madhunapantula SV; Kesharwani SS; Dey S; Jain V
Colloids Surf B Biointerfaces; 2021 Mar; 199():111535. PubMed ID: 33360926
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
[TBL] [Abstract][Full Text] [Related]
12. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
Emami J; Yousefian H; Sadeghi H
J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
[TBL] [Abstract][Full Text] [Related]
13. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
15. Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers.
Yu G; Ali Z; Sajjad Khan A; Ullah K; Jamshaid H; Zeb A; Imran M; Sarwar S; Choi HG; Ud Din F
Int J Nanomedicine; 2021; 16():3255-3273. PubMed ID: 34012260
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
17. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
18. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
19. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
20. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]